Toxicologic Pathology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bendele, A.
Right arrow Articles by Guy, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bendele, A.
Right arrow Articles by Guy, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Toxicologic Pathology, Vol. 27, No. 1, 134-142 (1999)
DOI: 10.1177/019262339902700125

Animal Models of Arthritis: Relevance to Human Disease

Alison Bendele

BolderPATH, Inc., University of Colorado. MCD Biology. Boulder, Colorado 80309.

Jennifer Mccomb

BolderPATH, Inc., Boulder, Colorado 80309

TY Gould

BolderPATH, Inc., Boulder, Colorado 80309

Tracy Mcabee

BolderPATH, Inc., Boulder, Colorado 80309

Gina Sennello

BolderPATH, Inc., Boulder, Colorado 80309

Elizabeth Chlipala

BolderPATH, Inc., Boulder, Colorado 80309

Michael Guy

BolderPATH, Inc., Boulder, Colorado 80309

Animal models of arthritis are used to evaluate potential antiarthritis drugs for clinical use. Therefore capacity of the model to predict efficacy in human disease is one of the most important criteria in model selection. Animal models of rheumatoid arthritis (RA) with a proven track record of predictability include rat adjuvant arthritis, rat type II collagen arthritis, mouse type II collagen arthritis, and antigen-induced arthritis in several species. Agents currently in clinical use (or trials) that are active in these models include corticosteroids, methotrexate, nonsteroidal anti-inflammatory drugs, cyclosporin A, leflunomide, interleukin-1 receptor antagonist, and soluble tumor necrosis factor receptors. For some of these agents, the models also predict that toxicities seen at higher doses for prolonged periods would preclude dosing in humans at levels that might provide disease-modifying effects. Animal models of osteoarthritis (OA) include mouse and guinea pig spontaneous OA, meniscectomy and ligament transection in guinea pigs, meniscectomy in rabbits, and meniscectomy and cruciate transection in dogs. None of these models have a proven track record of predictability in human disease because there are no agents that have been proven to provide anything other than symptomatic relief in human OA. Efficacy data and features of the various models of RA and OA are discussed with emphasis on their proven relevence to human disease.

Key Words: Rheumatoid arthritis • osteoarthritis • adjuvant arthritis • type II collagen arthritis • guinea pig • methotrexate • dexamethasone • indomethacin • interleukin 1 receptor antagonist • tumor necrosis factor receptor


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Lab AnimHome page
Y.-X. Wang
In vivo magnetic resonance imaging of animal models of knee osteoarthritis
Lab Anim, July 1, 2008; 42(3): 246 - 264.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. E. Kearns, S. Khosla, and P. J. Kostenuik
Receptor Activator of Nuclear Factor {kappa}B Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease
Endocr. Rev., April 1, 2008; 29(2): 155 - 192.
[Abstract] [Full Text] [PDF]


Home page
ptjournalHome page
Y.-L. Hsieh
Effects of Ultrasound and Diclofenac Phonophoresis on Inflammatory Pain Relief: Suppression of Inducible Nitric Oxide Synthase in Arthritic Rats
Physical Therapy, January 1, 2006; 86(1): 39 - 49.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
E. Larsson, H. Erlandsson Harris, A. Larsson, B. Mansson, T. Saxne, and L. Klareskog
Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP
Rheumatology, April 1, 2004; 43(4): 428 - 434.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
R. E. Guzman, M. G. Evans, S. Bove, B. Morenko, and K. Kilgore
Mono-Iodoacetate-Induced Histologic Changes in Subchondral Bone and Articular Cartilage of Rat Femorotibial Joints: An Animal Model of Osteoarthritis
Toxicol Pathol, October 1, 2003; 31(6): 619 - 624.
[Abstract] [PDF]


Home page
Ann Rheum DisHome page
D H. Jones, Y-Y Kong, and J M Penninger
Role of RANKL and RANK in bone loss and arthritis
Ann Rheum Dis, November 1, 2002; 61(90002): ii32 - 39.
[Abstract] [Full Text] [PDF]